Watch Video View / Download Official Testimony … [Read more...] about Grace-Marie Turner testifies on Medicare For All
Last fall, I wrote in Forbes about U.S. based biotechnology manufacturer Amgen announcing it was slashing the list price of its breakthrough cholesterol-lowering drug Repatha by 60% in an effort to improve access and affordability for patients. Too many patients who had been prescribed the drug were walking away from the pharmacy empty handed because of sticker shock over … [Read more...] about A Closer Look At The Drug Rebate Proposal
Critics cried sabotage when political leaders took action to repair some of the damage done by the Affordable Care Act. They saw sinister motives behind the decision by the last Congress to repeal the individual mandate and in Trump administration regulations that made more affordable health insurance options available to individuals and small groups. But a new study by the … [Read more...] about The Costs of Government’s Benevolent Coercion
If they said it once, they said it 200 at times. At a recent hearing before the House Energy and Commerce Health subcommittee (live-streamed here), the majority members repeatedly called the new Short Term Limited Duration plan option “Junk Plans.” House Committee on Energy & Commerce - Feb 13, 2019 In my testimony, I talked about the benefits these plans offer to people who are … [Read more...] about Do Democrats Want to Roll Back Consumer-Friendly Health Options?
Galen Institute president Grace-Marie Turner testified before the House Energy and Commerce Committee on Feb. 13 about preserving consumer protections in health insurance while giving consumers more choices of affordable coverage. She focused on: The Trump administration’s Section 1332 guidance which gives states new authority to help their individual and small group markets heal … [Read more...] about Preserving Patient Choice for Affordable Coverage